Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;27(8):724-725.
doi: 10.1111/nep.14043. Epub 2022 Apr 15.

Gemcitabine-induced renal thrombotic microangiopathy

Taro Horino  1 , Satoshi Inotani  1 , Masayuki Ishihara  2 , Yoshio Terada  1
Affiliations

Gemcitabine-induced renal thrombotic microangiopathy

Taro Horino et al. Nephrology (Carlton). 2022 Aug.
No abstract available

Keywords: acute kidney injury; cutaneous T-cell lymphoma; gemcitabine; nephrotic syndrome; thrombotic microangiopathy.

PubMed Disclaimer

References

REFERENCES

    1. Humphreys BD, Sharman JP, Henderson JM, et al. Gemcitabine-associated thrombotic microangiopathy. Cancer. 2004;100:2664-2670.
    1. Efe O, Goyal L, Galway A, Zhu AX, Niles JL, Zonozi R. Treatment of gemcitabine-induced thrombotic microangiopathy followed by gemcitabine rechallenge with eculizumab. Kidney Int Rep. 2021;6:1464-1468.
    1. Blake-Haskins JA, Lechleider RJ, Kreitman RJ. Thrombotic microangiopathy with targeted cancer agents. Clin Cancer Res. 2011;17:5858-5866.
    1. Katagiri D, Hinoshita F. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome. CEN Case Rep. 2018;7:217-220.
    1. Brocklebank V, Wood KM, Kavanagh D. Thrombotic microangiopathy and the kidney. Clin J Am Soc Nephrol. 2018;13:300-317.

MeSH terms

LinkOut - more resources